Home1S70 • FRA
add
Cartesian Therapeutics Inc
Previous close
€8.35
Day range
€8.85 - €8.90
Year range
€8.15 - €24.40
Market cap
266.29M USD
Avg Volume
8.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 1.10M | -80.33% |
Operating expense | 8.32M | -11.07% |
Net income | -17.71M | 68.83% |
Net profit margin | -1.61K | -444.97% |
Earnings per share | — | — |
EBITDA | -20.73M | -61.16% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 180.43M | 74.47% |
Total assets | 409.13M | 25.81% |
Total liabilities | 430.92M | -2.51% |
Total equity | -21.79M | — |
Shares outstanding | 25.95M | — |
Price to book | -9.94 | — |
Return on assets | -12.96% | — |
Return on capital | 20,230.13% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -17.71M | 68.83% |
Cash from operations | -23.11M | -45.18% |
Cash from investing | -1.08M | -78.57% |
Cash from financing | -8.02M | -118.65% |
Net change in cash | -32.18M | -221.39% |
Free cash flow | -20.59M | 36.90% |
About
Founded
2007
Headquarters
Website
Employees
66
